1 Min Read
Oct 12 (Reuters) - Steadymed Ltd:
* Steadymed receives notice of allowance for its European patent relating to enhanced reduction of infusion-site pain Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.